For comments, suggestions
Created with Raphaël 2.1.0 03.05.2019 Filing date 30.11.2020 Validation fee payment 31.03.2021 (A1) Patent application published 02.12.2024 AGEPI application filing date 31.03.2025 (T2) Translation of the validated European patent 17.06.2026 03.05.2027 Valid until 04.05.2028 Renewal fee to be paid until 03.05.2039 Patent will expire on

Patent in force


(210)Number of the EPO application19724676
(220)Filing date of the EPO application2019.05.03
(80)EPO patent specification publication (B)EPB nr. 36/2024, 2024.09.04
(110)EPO patent number3788047
(11)Number of the documentMD 3788047 T2
(21)Number of the applicatione 2021 0216
(71)Name(s) of applicant(s), code of the countryINCYTE CORPORATION, US;
(72)Name(s) of inventor(s), code of the countryBURN Timothy C., US;
LIU Phillip C., US;
FRIETZE William, US;
JIA Zhongjiang, US;
TAO Ming, US;
WANG Dengjin, US;
ZHOU Jiacheng, US;
LI Qun, US;
(73)Name(s) of owner(s), code of the countryINCYTE CORPORATION, US;
(54)Title of the inventionSolid forms of an fgfr inhibitor and processes for preparing the same
(13)Kind-of-document code T2
(51)International Patent Classification C07D 471/14 (2006.01.01); A61K 31/519 (2006.01.01); A61P 35/00 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2021.03.31
(49)Date of publication of the translation of the validated European patent specification2025.03.31
(30)Priority201862667166 P, 2018.05.04, US; 201962815539 P, 2019.03.08, US
(74)Patent attorney(Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova
(86)International applicationPCT/US2019/030633, 2019.05.03
(87)International publicationWO 2019/213544, 2019.11.07
Up
/Inventions/details/3788047